Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors
-
* Corresponding author: Anne E Lykkesfeldt al@cancer.dk
Breast Cancer Research 2009, 11:R11 doi:10.1186/bcr2230
No comments have yet been made on this article.